Offstream
news

Georgia receives 43,200 doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.
2021-07-10

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

Yemen begins their COVID-19 vaccination campaign using the vaccine produced by AstraZeneca and the University of Oxford.
2021-04-20

The Haiti government rejects an offer from the World Health Organization to receive 756,000 doses of the vaccine produced by AstraZeneca.
2021-04-6

Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.
2021-03-22

The Therapeutic Goods Administration approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca for people over 18 years of age in Australia.
2021-02-16

AstraZeneca-Oxford developers say that their vaccine candidate is effective against the UK variant of SARS-CoV-2.
2021-02-5

Kyrgyzstan is expected to receive 504,000 doses of the Oxford-AstraZeneca vaccine in March.
2021-02-2

South Africa approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country.
2021-01-27

Brazil begins distribution of the AstraZeneca-Oxford University vaccine.
2021-01-23